Management of cervical dystonia with botulinum neurotoxins and EMG/ultrasound guidance

Research output: Contribution to journalReview articlepeer-review


Purpose of reviewWe provide a practical guide on the use of electromyography (EMG) and ultrasound (US) to assist botulinum neurotoxin (BoNT) treatment in patients with cervical dystonia (CD).Recent findingsUS and EMG guidance improve BoNT treatment in CD. Their use is particularly valuable for targeting deep neck muscles and managing complex cases. There is also evidence that adverse events are reduced when superficial or intermediate layer muscles are injected with assisted guidance.SummaryA structured clinical approach, based on functional neck anatomy, guides CD assessment and BoNT treatment. Muscles are selected according to clinical, EMG and US findings. US provides anatomical visualization, while EMG complements by detecting muscle activity. We review here the current practice for assisted treatment of CD through BoNT cycles. We also describe how to recognize and manage the main adverse events.

Original languageEnglish
Pages (from-to)64-73
Number of pages10
JournalNeurology: Clinical Practice
Issue number1
Publication statusPublished - Feb 1 2019

ASJC Scopus subject areas

  • Clinical Neurology

Fingerprint Dive into the research topics of 'Management of cervical dystonia with botulinum neurotoxins and EMG/ultrasound guidance'. Together they form a unique fingerprint.

Cite this